Colony NorthStar (CLNS) Cut to “Sell” at ValuEngine

ValuEngine downgraded shares of Colony NorthStar (NYSE:CLNS) from a hold rating to a sell rating in a research note issued to investors on Monday.

A number of other equities analysts have also issued reports on CLNS. JMP Securities raised shares of Colony NorthStar from a market perform rating to an outperform rating and set a $13.00 target price on the stock in a research report on Friday, January 5th. Zacks Investment Research lowered shares of Colony NorthStar from a hold rating to a sell rating in a research report on Wednesday, January 10th. B. Riley reaffirmed a buy rating and set a $15.00 target price on shares of Colony NorthStar in a research report on Monday, January 22nd. Royal Bank of Canada reaffirmed an outperform rating and set a $19.00 target price on shares of Colony NorthStar in a research report on Wednesday, January 31st. Finally, Keefe, Bruyette & Woods reaffirmed a hold rating and set a $6.00 target price on shares of Colony NorthStar in a research report on Friday, March 2nd. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the stock. Colony NorthStar presently has an average rating of Hold and an average price target of $12.00.

How to Become a New Pot Stock Millionaire

CLNS stock traded down $0.01 on Monday, reaching $5.57. 1,250,963 shares of the company were exchanged, compared to its average volume of 9,099,269. Colony NorthStar has a 12 month low of $5.28 and a 12 month high of $14.74. The company has a quick ratio of 5.14, a current ratio of 5.14 and a debt-to-equity ratio of 1.01.

Colony NorthStar (NYSE:CLNS) last announced its earnings results on Thursday, March 1st. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.24 by ($0.08). Colony NorthStar had a negative return on equity of 1.86% and a negative net margin of 7.08%. The company had revenue of $720.30 million for the quarter, compared to the consensus estimate of $755.19 million. The firm’s quarterly revenue was up 245.5% compared to the same quarter last year. analysts anticipate that Colony NorthStar will post 0.46 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Friday, March 30th will be issued a $0.11 dividend. This represents a $0.44 annualized dividend and a yield of 7.90%. The ex-dividend date is Wednesday, March 28th.

In other Colony NorthStar news, Director John Steffens purchased 10,000 shares of the stock in a transaction on Tuesday, March 6th. The shares were purchased at an average price of $5.94 per share, with a total value of $59,400.00. Following the acquisition, the director now directly owns 61,690 shares of the company’s stock, valued at approximately $366,438.60. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders own 7.99% of the company’s stock.

A number of institutional investors have recently made changes to their positions in CLNS. Legal & General Group Plc increased its holdings in Colony NorthStar by 10.9% in the 3rd quarter. Legal & General Group Plc now owns 564,025 shares of the real estate investment trust’s stock valued at $7,085,000 after buying an additional 55,336 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Colony NorthStar by 79.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 905,809 shares of the real estate investment trust’s stock valued at $11,368,000 after purchasing an additional 402,062 shares in the last quarter. Schroder Investment Management Group boosted its stake in shares of Colony NorthStar by 189.9% in the 3rd quarter. Schroder Investment Management Group now owns 81,355 shares of the real estate investment trust’s stock valued at $1,021,000 after purchasing an additional 53,295 shares in the last quarter. Wells Fargo & Company MN boosted its stake in shares of Colony NorthStar by 104.7% in the 3rd quarter. Wells Fargo & Company MN now owns 2,210,035 shares of the real estate investment trust’s stock valued at $27,758,000 after purchasing an additional 1,130,318 shares in the last quarter. Finally, Confluence Investment Management LLC boosted its stake in shares of Colony NorthStar by 1.7% in the 4th quarter. Confluence Investment Management LLC now owns 5,901,611 shares of the real estate investment trust’s stock valued at $67,337,000 after purchasing an additional 97,345 shares in the last quarter. 82.84% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/04/06/colony-northstar-clns-cut-to-sell-at-valuengine.html.

Colony NorthStar Company Profile

Colony NorthStar, Inc is a diversified equity real estate investment trust (REIT). The Company combines a portfolio of real assets across the world, which are managed with a global real estate investment manager. The Company has property holdings in the healthcare, industrial and hospitality sectors, opportunistic equity and debt investments, and an embedded institutional and retail investment management business.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Colony NorthStar (NYSE:CLNS)

Receive News & Ratings for Colony NorthStar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colony NorthStar and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply